AJR 2004; 183:437-442
© American Roentgen Ray Society
Relationship Between Various Patterns of Transient Increased Hepatic Attenuation on CT and Portal Vein Thrombosis Related to Acute Cholecystitis
Seung Hong Choi1,
Jeong Min Lee,
Kyoung Ho Lee,
Se Hyung Kim,
Young Jun Kim,
Su Kyung An,
Joon Koo Han and
Byung Ihn Choi
1 All authors: Department of Radiology and Institute of Radiation Medicine,
Seoul National University Hospital, 28, Yongon-dong, Chongno-gu, Seoul
110-744, South Korea.
Received November 21, 2003;
accepted after revision March 1, 2004.
Address correspondence to J. M. Lee
(leejm{at}radcom.snu.ac.kr).
Abstract
OBJECTIVE. We sought to investigate the prevalence of portal vein
thrombosis in patients with acute cholecystitis and the relationship between
portal vein thrombosis and the various patterns of transient increased hepatic
attenuation on CT.
MATERIALS AND METHODS. We studied 72 of 107 patients with acute
cholecystitis who, during a 3-year period, underwent dual-phase
contrast-enhanced CT before percutaneous cholecystostomy or cholecystectomy.
CT scans were retrospectively reviewed for the presence of portal vein
thrombosis and location of the thrombi and for patterns of transient increased
hepatic attenuation, which were classified as either pericholecystic,
segmental, or mixed.
RESULTS. Portal vein thrombi (two in hepatic segment IV, three in
the left portal vein, and one in the right posterior portal vein) were found
in six (8.3%) of 72 patients, and in those patients, transient increased
attenuation with a segmental (five patients) or mixed (one patient) pattern
was seen on CT. The pattern of transient increased attenuation in the 54
patients without portal vein thrombosis was pericholecystic in 41 (75.9%) and
mixed in 13 (24.1%). Nineteen patients had segmental distribution (segmental
or mixed pattern) that in 31.6% (6/19) of the patients was associated with
portal vein thrombosis. Segmental distribution was more frequently found in
those patients who had acute cholecystitis with portal vein thrombosis than in
those who had only acute cholecystitis (p = 0.001).
CONCLUSION. In patients with acute cholecystitis, portal vein
thrombosis is not uncommon. Patterns of transient increased hepatic
attenuation were found to vary, depending on the presence or absence of portal
vein thrombosis.
Introduction
Transient focal increased attenuation of the liver is often found on CT
scans in patients with acute cholecystitis. It is well known that in such
patients, curvilinear areas of transient increased attenuation are seen during
the early phase of incremental dynamic CT in the liver adjacent to the
gallbladder fossa [1].
Moreover, the parabiliary veins and the cystic vein of the gallbladder have
been depicted on angiography as entering the liver
[2]. Given that acute
cholecystitis has been reported to cause hepatic arterial hyperemia and early
venous drainage, the curvilinear transient enhancement near the gallbladder in
patients with acute cholecystitis has also been attributed to increased blood
flow from the dilated aberrant cystic vein of the diseased hypervascular
gallbladder [1,
3].
Because of hepatic artery enlargement and increased relative hepatic artery
perfusion in regions of portal occlusion, transient hyperattenuation may occur
in the region of portal occlusion and be observed during arterial phase CT
[4,
5]. Therefore, portal vein
thrombosis is one potential cause of transient increased hepatic attenuation
on CT. Two articles reporting adults with portal vein thrombosis related to
acute cholecystitis have appeared in the literature
[6,
7]. However, to our knowledge,
the prevalence and CT depictions of portal vein thrombosis related to acute
cholecystitis have not been studied.
The purposes of our study were to determine the prevalence of portal vein
thrombosis in patients with acute cholecystitis and to investigate the
relationship between portal vein thrombosis in patients with acute
cholecystitis and the various patterns of transient increased hepatic
attenuation on CT.
Materials and Methods
We identified patients who had undergone emergency percutaneous
cholecystostomy or cholecystectomy because of acute cholecystitis by reviewing
hospital discharge records for a 3-year period (between January 2000 and
December 2002). We identified 107 patients and cross-referenced this list with
radiology files to identify patients in whom CT scans had been obtained before
the procedure. We found 72 (67%) of these 107 patients had CT scans, and these
72 patients (52 men and 20 women; age range, 33-89 years; mean, 65 years) were
our study population. All 72 patients were hospitalized for suspected acute
cholecystitis and underwent preprocedural contrast-enhanced CT after
sonography. Of these 72 patients, 24 underwent emergency cholecystectomy only.
Of the 48 patients who underwent percutaneous cholecystostomy, 25 subsequently
underwent elective open or laparoscopic cholecystectomy, and 23 were only
observed. Diagnostic aspirations were performed in all patients who underwent
percutaneous cholecystostomy. The time interval between surgery or
percutaneous cholecystostomy and CT examination was less than 5 days in all
patients.
Patients were judged to have acute cholecystitis if pathologic examination
revealed acute inflammation (n = 42); if bile cultures obtained after
diagnostic aspiration of the gallbladder produced positive results (n
= 11); or if symptoms markedly improved after percutaneous cholecystostomy
(n = 19). Patients in whom gallstones were identified at pathologic
examination (n = 45) were considered to have calculous cholecystitis.
Patients in whom gallstones were not identified at pathologic examination or
on preoperative sonography or CT (n = 27) were considered to have
acalculous cholecystitis.
Twenty-two of the 72 patients had a primary diagnosis in addition to acute
cholecystitis. Among the patients with an additional primary diagnosis, those
with liver metastases (n = 2, one case of lung cancer and one case of
rectal cancer), primary liver cancer (n = 5), or distal common bile
duct cancer (n = 2) had various hepatic enhancement patterns of their
hepatic lesions or cholangitis on CT. Therefore, we excluded those hepatic
segments (3% or 17/576 segments in 22 patients) that showed varying hepatic
enhancement patterns on contrast-enhanced CT, which is suggestive of primary
liver cancer, metastasis, or cholangitis, from the analysis of hepatic
parenchymal CT attenuation differences
(Table 1). In 13 patients
admitted for other primary diagnosesincluding stomach cancer
(n = 5), renal cell carcinoma (n = 3), congestive heart
failure (n = 1), malignant melanoma (n = 1), lymphoma
(n = 1), leukemia (n = 1), and systemic lupus erythematosus
(n = 1)no abnormal findings in the liver were observed other
than the presumed transient increased hepatic attenuation associated with
acute cholecystitis (Table
1).
For the limited and anonymous review of patient data required for this
study, the institutional review board of our hospital did not require us to
obtain formal approval or informed patient consent.
Because our study was retrospective, the CT examinations were performed
using different scanners (Somatom Plus S or Somatom Plus 4, Siemens Medical
Systems; HiSpeed Advantage CT scanner, GE Healthcare; MX 8000, Marconi Medical
Systems), and the CT techniques used varied. In general, examinations were
performed using a helical technique with 5-10 mm collimation, a pitch of
1.0-1.4, and reconstruction intervals of 5-10 mm. The X-ray tube voltage was
120-140 kV, and the current was 150-220 mA. During the study period, our
standard protocol for dynamic CT required a total volume of 100-150 mL of
nonionic IV contrast material (300-370 mg I/mL) administered by power
injection at a rate of 3 mL/sec, with a scanning delay of 30-40 sec for the
hepatic arterial phase and 60-80 sec for the portal venous phase.
CT scans were reviewed by two experienced abdominal radiologists who
interpreted the scans in consensus without knowledge of the contents of the CT
report or final diagnosis of any patient. The radiologists evaluated the scans
for the presence and appearance of increased hepatic parenchymal attenuation
during the hepatic arterial phase of dual-phase CT and then for the presence
and the extent of portal vein thrombosis within the hepatic lesion with
increased parenchymal attenuation during the portal venous phase of dual-phase
CT.
Increased hepatic parenchymal CT attenuation was judged to be present
during the hepatic arterial phase if the two reviewers reached a consensus
interpretation of this condition without significant discrepancy, which they
did in all cases. Patterns of increased hepatic parenchymal CT attenuation
during the hepatic arterial phase were classified as pericholecystic (within
the hepatic area adjacent to the gallbladder), segmental, or mixed
(pericholecystic and segmental)
[3]. The presence of peripheral
wedge-shaped arterial phase areas of hyperenhancement distal to segmental
thrombi was documented after the identification of portal vein thrombi on CT
scans obtained during the portal venous phase. Thrombi were identified as
low-attenuation, intraluminal filling defects in the veins
[8]. When thrombi were
identified, their specific locations were documented. These included the main
portal vein, the right and left portal veins, and any segmental veins.
Segmental thrombi were identified as tubular structures in the portal triad
that connected to an enhanced portal venous structure located more proximally
in the liver [9]. Segmental
involvement was described using the Couinaud nomenclature
[10].
All scans were reviewed on a PACS (Marotech) monitor, which allows rapid
manual cine evaluation through the liver and upper abdomen, thus enabling the
physicians to easily identify intraluminal filling defects and to associate
them with the portal venous system. Reviewing on a PACS also allows window and
level settings of images of the hepatic parenchyma to be easily changed.
The relationship between the presence of portal vein thrombosis and a
transient increased hepatic attenuation pattern was examined using Fisher's
exact test. A p value of less than 0.05 was considered a
statistically significant difference. All statistical analyses were performed
using the Statistical Package for the Social Sciences software package
(version 10.0, SPSS).
Results
Sixty (83.3%) of the 72 patients with acute cholecystitis showed transient
increased attenuation within the hepatic area (pericholecystic or segmental
distribution) on CT scans obtained during hepatic arterial phase. Portal vein
thrombi were found in six (8.3%) of the 72 patients with acute cholecystitis,
and these six patients had no other clinical problems except acute
cholecystitis. Table 2 lists
the locations of the portal vein thrombi as well as the locations and
appearances of transient hepatic parenchymal hyperattenuation in six patients
with portal vein thrombosis (Figs.
1A,
1B,
1C,
2A,
2B,
3A,
3B). All patients with portal
vein thrombosis had segmental distribution (segmental [n = 5] or
mixed [n = 1]) of transient increased hepatic attenuation.
Wedge-shaped areas of hyperenhancement distal to or corresponding to the
segmental location of the thrombus were identified in two patients with
segmental portal vein thrombosis. This finding was often subtle and was
identified only using manually adjusted narrow window and level settings. Such
areas of hyper-enhancement were not present on any of the scans on which
thrombi were not identified.
View this table:
[in this window]
[in a new window]
|
TABLE 2 Location of Portal Vein Thrombosis and Location and Pattern of Transient
Increased Hepatic Attenuation in Six Patients
|
|

View larger version (92K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A. 62-year-old woman with portal vein thrombosis related to acute
cholecystitis in segment IV of liver. CT scan obtained during hepatic arterial
phase shows transient increased hepatic attenuation (arrows) with
segmental distribution in segment IV.
|
|

View larger version (70K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B. 62-year-old woman with portal vein thrombosis related to acute
cholecystitis in segment IV of liver. CT scan obtained during hepatic arterial
phase shows transient increased hepatic attenuation (arrows) with
curvilinear appearance in pericholecystic gallbladder fossa of liver.
|
|

View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C. 62-year-old woman with portal vein thrombosis related to acute
cholecystitis in segment IV of liver. CT scan obtained during portal venous
phase shows occlusive thrombus (arrowhead) with low attenuation in
segment IV.
|
|

View larger version (102K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A. 76-year-old woman with portal vein thrombosis related to acute
cholecystitis in segments VI and VII of liver. CT scan obtained during hepatic
arterial phase shows transient increased hepatic attenuation (arrows)
with segmental distribution in segments VI and VII.
|
|

View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B. 76-year-old woman with portal vein thrombosis related to acute
cholecystitis in segments VI and VII of liver. CT scan obtained during portal
venous phase reveals occlusive thrombi (arrowheads) with low
attenuation in segments VI and VII.
|
|

View larger version (88K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3A. 69-year-old woman with portal vein thrombosis related to acute
cholecystitis in left portal vein. CT scan obtained during hepatic arterial
phase shows transient increased hepatic attenuation (arrows) with
lobar distribution in left lobe of liver.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3B. 69-year-old woman with portal vein thrombosis related to acute
cholecystitis in left portal vein. CT scan obtained during portal venous phase
reveals occlusive thrombus (arrowhead) with low attenuation in left
portal vein.
|
|
Of the 54 patients without portal vein thrombosis, 41 (75.9%) had a
pericholecystic pattern of transient increased attenuation within the hepatic
area adjacent to the gallbladder (Fig.
4), and 13 (24.1%) had a mixed pattern (Fig.
5A,
5B). Of the 13 patients with a
mixed pattern, six showed transient increased attenuation within hepatic
segments IV (segmental pattern) and V (pericholecystic pattern), and seven
showed such attenuation within segments II, III, IV (all three, segmental
pattern) and V (pericholecystic pattern)
(Table 3). A total of 19
patients had segmental transient increased hepatic attenuation, and 13 of
these patients did not have portal vein thrombosis. Therefore, segmental
transient increased hepatic attenuation was associated with portal vein
thrombosis in 31.6% of the patients. The segmental
distributionincluding segmental (n = 5) or mixed (n =
1) patternof transient increased hepatic attenuation adjacent to the
gallbladder on CT was more frequently found in the patients with portal vein
thrombosis (p = 0.001). However, the pericholecystic transient
increased hepatic attenuation (n = 1) was less frequently found in
these patients (p = 0.0001).

View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4. 74-year-old man with acute gangrenous cholecystitis. CT scan
obtained during hepatic arterial phase shows transient increased hepatic
attenuation (thick solid arrow) with curvilinear appearance in
pericholecystic gallbladder fossa of liver. Note intraluminal gas collection
(thin solid arrow) in gallbladder fundus and pericholecystic
infiltration (open arrow).
|
|

View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A. 62-year-old man with gallbladder empyema. CT scan obtained during
hepatic arterial phase shows transient increased hepatic attenuation
(arrows) with lobar distribution in left lobe of liver.
|
|

View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B. 62-year-old man with gallbladder empyema. CT scan obtained during
hepatic arterial phase shows transient increased hepatic attenuation
(solid arrow) with curvilinear appearance in pericholecystic
gallbladder fossa of liver. Note pericholecystic fluid collection (open
arrow).
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3 Location and Pattern of Transient Increased Hepatic Attenuation in 54
Patients Without Portal Vein Thrombosis
|
|
Discussion
In our study, the frequency of transient increased hepatic attenuation on
hepatic arterial phase CT images was 83.3% (60/72 patients), which is higher
than the frequency of such attenuation in the healthy adults (3%)
[3]. Portal vein thrombosis was
found in six (8.3%) of 72 patients with acute cholecystitis. Transient
increased hepatic attenuation can occur in patients with acute cholecystitis
with or without portal vein thrombosis. All patients with portal vein
thrombosis had transient increased hepatic attenuation with a segmental
pattern, and the portal vein thrombus was always in the segment with transient
increased hepatic attenuation. One of the six patients exhibited not only a
segmental but also a pericholecystic pattern of transient increased hepatic
attenuation. Of the 66 patients without portal vein thrombosis detectable on
CT, 54 (82%) had pericholecystic (n = 41) or mixed (n = 13)
transient increased hepatic attenuation. None of these patients had purely
segmental transient increased hepatic attenuation. These results suggest that
acute cholecystitis contributes to transient increased hepatic attenuation on
contrast-enhanced CT scans and that there is a difference in the hemodynamic
mechanism of transient increased hepatic attenuation in patients with portal
vein thrombosis related to acute cholecystitis and in patients with acute
cholecystitis only.
Transient increased attenuation in the liver has been frequently observed
in the patients with gallbladder disease on dynamic CT, MRI, angiography, or
CT arterioportography [1,
3,
11-13].
Increased venous drainage attributed to hyperemia associated with acute
cholecystitis is one cause of the transient increased attenuation of the
liver, according to Matsui et al.
[2]. Ito et al.
[3] also reported various
patterns of transient increased hepatic attenuation in patients with
gallbladder diseases, including chronic cholecystitis, gallbladder cancer, and
adenomyomatosis, in addition to pericholecystic hepatic enhancement. Those
researchers suggested that increased cystic venous drainage might contribute
to transient increased hepatic attenuation. Moreover, CT angiography has shown
that the cystic veins that emerge from the body or fundus of the gallbladder
flow mainly into the subsegmental portal branches or sinusoids of segment IV
or V and that the veins that emerge from the neck of the gallbladder flow into
the more proximal portal branches
[13]. This fact correlates
well with the results of our study in that we found that the main hepatic
areas with transient increased hepatic attenuation were segments IV and V.
Because of these variations in the termination of the cystic vein, transient
increased hepatic attenuation could possibly appear in these segments in a
variable fashion in addition to appearing in the liver parenchyma around the
gallbladder fossa [3]. However,
in patients with acute cholecystitis who had portal vein thrombosis, another
hemodynamic mechanism that induces transient increased hepatic attenuation
might play an important role. We believe that in the patients with portal vein
thrombosis, hepatic arterial hyperperfusion of the involved hepatic segments
is responsible for segmental distribution of transient increased hepatic
attenuation
[14-18].
In addition, the pericholecystic transient increased hepatic attenuation,
which was thought to be caused by increased venous drainage through a direct
vascular channel between the liver and the gallbladder, was found in only one
of the patients with portal vein thrombosis. These results suggest that the
thrombi associated with acute cholecystitis can obliterate various vascular
channels between the gallbladder and the liver, as was described earlier.
Portal vein thrombosis is a condition that is either caused by or
associated with a variety of factors and diseases
[8,
19-22].
The condition includes various infectious and inflammatory processes, such as
the invasion or compression of the vein by a tumor (usually a hepatocellular
carcinoma or pancreatic adenocarcinoma), hypercoagulable states, and
mechanical manipulation [8,
19-22].
However, in our patients with portal vein thrombosis, no other clinical
conditions known to cause portal vein thrombosis were found. In patients with
acute cholecystitis and portal vein thrombosis, the portal vein thrombosis may
have been the result of an inflammation or of an infection reaching the cystic
vein. Two possible paths of infection are proposed: a connection between the
cystic vein and the hepatic sinusoid or a connection between the cystic and
portal veins. In cases in which a connection between the cystic vein and the
hepatic sinusoid plays an important role in portal vein thrombosis, a direct
spread of infection and inflammation from the gallbladder to the portal vein
is the main cause of thrombosis. Small portal vein thrombi are believed to
play an important role in cases in which a connection between the cystic and
portal veins provides an infectious and inflammatory path in portal vein
thrombosis. Thus, portal vein thrombosis associated with acute cholecystitis
could be present in hepatic segments II, III, and VII as well as in
pericholecystic hepatic segments (segments IV and V).
We recognize that our study has limitations. Patients with portal vein
thrombosis did not undergo follow-up CT after cholecystectomy or percutaneous
cholecystostomy for the evaluation of changes in portal vein thrombosis. Only
one patient received follow-up sonography, which showed the absence of portal
vein thrombosis. We were unable to find any factors other than acute
cholecystitis predisposing patients with portal vein thrombosis to the
disease. Moreover, patients improved clinically after undergoing
cholecystectomy or percutaneous cholecystostomy and were discharged without
clinical problems. Our study is likely to have a selection bias because we
included patients with acute cholecystitis who were referred for CT
evaluation. Some patients judged to have acute cholecystitis did not undergo
CT before treatment but had sonography instead. CT is required to reveal
complications related to cholecystitis, such as gallbladder perforation with
pericholecystic abscess or emphysematous cholecystitis
[23,
24]. Although we do not know
the indications that led to our patients being referred for CT, it is possible
that those patients who were the most ill tended to receive these
referrals.
In summary, portal vein thrombosis associated with acute cholecystitis is
not rare, and patterns of transient increased hepatic attenuation on CT scans
vary, depending on the presence or absence of portal vein thrombosis.
Segmental distribution, which includes segmental and mixed patterns, of
transient increased hepatic attenuation was also observed on the scans of
patients with acute cholecystitis and without portal vein thrombosis, but we
believe that the hemodynamic mechanism underlying segmental transient
increased hepatic attenuation in such patients without portal vein thrombosis
differs from those with portal vein thrombosis. Increased hepatic arterial
blood flow through the parabiliary plexus may be responsible for the transient
increased hepatic attenuation in the patients with portal vein thrombosis.
Segmental transient increased hepatic attenuation in patients referred for
acute cholecystitis is strongly suggestive of portal vein thrombosis, and a
meticulous search for portal vein thrombi is warranted. Every patient with
portal vein thrombosis associated with acute cholecystitis had transient
increased hepatic attenuation in either a segmental pattern or segmental and
pericholecystic patterns.
References
- Yamashita K, Jin MJ, Hirose Y, et al. CT finding of transient focal
increased attenuation of the liver adjacent to the gallbladder in acute
cholecystitis. AJR1995; 164:343
-346[Abstract/Free Full Text]
- Matsui O, Takashima T, Kadoya M, et al. Staining in the liver
surrounding gallbladder fossa on hepatic arteriography caused by increased
cystic venous drainage. Gastrointest Radiol1987; 12:307
-312[Medline]
- Ito K, Awaya H, Mitchell DG, et al. Gallbladder disease: appearance
of associated transient increased attenuation in the liver at biphasic,
contrast enhanced dynamic CT. Radiology1997; 204:723
-728[Abstract/Free Full Text]
- Oliver JH III, Baron RL. Helical biphasic contrast-enhanced CT of
the liver: technique, indications, interpretation, and pitfalls.
Radiology1996; 201:1
-14[Abstract/Free Full Text]
- Baron RL, Oliver JH III, Dodd GD III, Nalesnik M, Holbert BL, Carr
B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced,
helical CT. Radiology1996; 199:505
-511[Abstract/Free Full Text]
- Harch JM, Radin RD, Yellin AE, Donovan AJ. Pylethrombosis:
serendipitous radiologic diagnosis. Arch Surg1987; 122:1116
-1119[Abstract]
- Kidney DD, Forino MT, Cohen AJ, Hunter V. Case report: portal
venous thrombosis in acute cholecystitis. CT, ultrasound, Doppler and power
Doppler findings. Clin Radiol1998; 53:459
-461[Medline]
- Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis.
N Engl J Med2001; 345:1683
-1688[Free Full Text]
- Baker ME, Remzi F, Einstein D, et al. CT depiction of portal vein
thrombi after creation of ileal pouchanal anastomosis.
Radiology2003; 227:73
-79[Abstract/Free Full Text]
- Dodd GD III. An American's guide to Couinaud's numbering system.
AJR 1993;161:574
-575[Free Full Text]
- Matsui O, Takahashi S, Kadoya M, et al. Pseudolesion in segment IV
of the liver at CT during arterial portography: correlation with aberrant
gastric venous drainage. Radiology1994; 193:31
-35[Abstract/Free Full Text]
- Loud PA, Semelka RC, Kettritz U, Brown JJ, Reinhold C. MRI of acute
cholecystitis: comparison with the normal gallbladder and other entities.
Magn Reson Imaging1996; 14:349
-355[Medline]
- Sugita M, Ryu M, Satake M, et al. Intrahepatic inflow areas of the
drainage vein of the gallbladder: analysis by angio-CT.
Surgery 2000;128:417
-421[Medline]
- Ternberg JL, Butcher HR Jr. Blood-flow relation between hepatic
artery and portal vein. Science1965; 150:1030
-1031[Abstract/Free Full Text]
- Itai Y, Matsui O. Blood flow and liver imaging.
Radiology1997; 202:306
-314[Free Full Text]
- Itai Y, Moss AA, Goldberg HI. Transient hepatic attenuation
difference of lobar or segmental distribution detected by dynamic computed
tomography. Radiology1982; 144:835
-839[Free Full Text]
- Matsui O, Takashima T, Kadoya M, et al. Segmental staining on
hepatic arteriography as a sign of intrahepatic portal vein obstruction.
Radiology1984; 152:601
-606[Abstract/Free Full Text]
- Choi BI, Chung JW, Itai Y, Matsui O, Han JK, Han MC. Hepatic
abnormalities related to blood flow: evaluation with dual phase helical CT.
Abdom Imaging1999; 24:340
-356[Medline]
- Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review.
Am J Med 1992;92:173
-182[Medline]
- Plemmons RM, Dooley DP, Longfield RN. Septic thrombophlebitis of
the portal vein (pylephlebitis): diagnosis and management in the modern era.
Clin Infect Dis1995; 21:1114
-1120[Medline]
- Valla DC, Condat B. Portal vein thrombosis in adults:
pathophysiology, pathogenesis, and management. J
Hepatol 2000;32:865
-871[Medline]
- Sheen CL, Lamparelli H, Milne A, Green I, Ramage JK. Clinical
features, diagnosis, and outcome of acute portal vein thrombosis. Q
J Med 2000;93:531
-534
- Lamki N, Raval B, St. Ville E. Computed tomography of complicated
cholecystitis. J Comput Assist Tomogr1986; 10:319
-324
- Varma DGK, Faust JM. Computed tomography of gangrenous acute
postoperative acalculous cholecystitis. J Comput Assist
Tomogr 1988;12:29
-31

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Altun, R. C. Semelka, J. Elias Jr, L. Braga, V. Voultsinos, J. Patel, N. C. Balci, and J. T. Woosley
Acute Cholecystitis: MR Findings and Differentiation from Chronic Cholecystitis
Radiology,
July 1, 2007;
244(1):
174 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|